Foghorn Therapeutics Inc. [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18
	10-K	10-K	10-K/A	10-K	S-1/A
Assets
Cash and equivalents	52.2	101.1	92.8	15.0	40.0
Short-term investments	293.6	53.2	93.0
Other current assets	5.6	305.3	4.9	1.9	0.4
Total current assets	351.4	459.6	190.7	16.9	40.4
Property, plant, and equipment, net				2.7	2.1
Other fixed assets	2.4	2.4	0.8	0.0
Total assets	404.9	519.8	255.6	22.3	43.1

Accounts payable	5.4	3.8	3.7	3.4	2.0
Accrued expenses	5.4	6.1	4.5	3.7	1.4
Current portion of long-term debt	0.0	0.0	0.0	4.2	0.0
Current portion of long-term debt				4.2
Other current liabilities	44.4	38.8	10.7	1.4
Total current liabilities	55.2	48.7	18.8	12.7	3.5
Long-term debt			19.7	11.0
Other liabilities	349.6	374.2	70.9	0.2	7.6
Total liabilities	404.8	422.9	109.4	23.8	11.1

Shareholders' equity [+]	0.1	96.9	146.2	-1.5	32.0
Paid-in capital	377.2	361.1	309.1	6.1	3.7
Retained earnings	-373.1	-264.3	-162.9	-94.1	-43.0
Tangible shareholders' equity	0.1	96.9	146.2	-1.5	32.0